checkAd

     181  0 Kommentare LexaGene Introduces its Commercial Product MiQLab - Seite 2

    Dr. Regan continues, “We are not only manufacturing the device, but also the associated consumables for our razor blade business model. Our consumables include the single use disposable cartridge for sample preparation as well as the PCR test chemistry, which MiQLab automates. At volume manufacturing, we expect the costs for our consumables to be substantially lower than competing technologies, which will allow us to maintain healthy profit margins even when selling into cost sensitive markets.”

    To start, the Company anticipates offering three sets of chemistries, namely a COVID-19 test ($5.2B market in 20208), a bacterial and antimicrobial panel for veterinary diagnostics that will screen for 8 different pathogens (E. coli, Proteus, Klebsiella, Enterobacter, Pseudomonas, Staphylococcus, Streptococcus and Enterococcus) and 12 antibiotic resistance factors including methicillin and vancomycin resistance, and an open-access panel to facilitate customized genetic testing.

    LexaGene has submitted a preliminary plan for COVID-19 testing to the FDA and is still in conversations with the agency regarding the proposed studies for this novel technology. As is standard practice, until the FDA grants LexaGene’s instrument EUA for COVID-19 testing, all work using LexaGene instruments is classified as Research Use Only and cannot be used for human clinical diagnostics.

    The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain COVID-19 (or SARS-2 Coronavirus) at this time.

    To be added to the LexaGene email list, please subscribe on the Company website.

    1 https://www.globenewswire.com/news-release/2019/07/16/1883243/0/en/Inf ...
    2 https://www.marketsandmarkets.com/Market-Reports/veterinary-infectious-disease-diagnostic-market-221816584.html#:~:text=%5B238%20Pages%20Report%5D%20The%20global,8.4%25%20from%202019%20to%202024.
    3 https://www.bccresearch.com/market-research/food-and-beverage/food-saf ...
    4 https://www.prnewswire.com/news-releases/the-global-real-time-pcr-and- ...
    5 https://www.marketsandmarkets.com/Market-Reports/genotyping-market-249 ...
    6 https://www.researchandmarkets.com/research/l7j8hj/microbiological
    7 https://www.prnewswire.com/news-releases/2018-agricultural-testing-glo ...

    Seite 2 von 3



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    LexaGene Introduces its Commercial Product MiQLab - Seite 2 Automated, genetic analyzer designed for rapid, point-of-need testingBEVERLY, Mass., July 13, 2020 (GLOBE NEWSWIRE) - LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops genetic …